CN-21 RISK MODELING FOR TEMOZOLOMIDE (TMZ)-MYELOTOXICITY IN PATIENTS WITH GLIOBLASTOMA TREATED ON RTOG 0825

BACKGROUND: TMZ is well tolerated with a relatively low incidence of myelotoxicity, which can nonetheless result in treatment delays or death. Our goal was to evaluate risk and validate prediction models in newly diagnosed patients treated with TMZ +/- bevacizumab (BEV). METHODS: Models (from recurr...

詳細記述

保存先:
書誌詳細
主要な著者: Zhou, Renke, Scheurer, Michael, Vera-Bolanos, Elizabeth, Gilbert, Mark, Bondy, Melissa, Sulman, Eric, Hilsenbeck, Sue, Wendland, Merideth, Brachman, David, Roof, Kevin, Komaki, Ritsuko, Deutsch, Melvin, Andrews, David, Anderson, Bethany, Lee, R. Jeffrey, Pugh, Stephanie, Armstrong, Terri
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2014
主題:
Abstracts
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218016/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou243.21
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料